Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S E Papapoulos

Showing results (11-20 of 162) with videos related to

Pageof 17
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|March 30, 1991
[Diphosphonates in the treatment of osteoporosis]S E Papapoulos, J H Lockefeer
Seminars in Nuclear Medicine|February 24, 2001
The palliative management of skeletal metastases in prostate cancer: use of bone-seeking radionuclides and bisphosphonatesN A Hamdy, S E Papapoulos
Nederlands Tijdschrift Voor Geneeskunde|August 26, 1989
[Alkaline phosphatase level in bone diseases; frequently too high, sometimes too low]J D Macfarlane, S E Papapoulos
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 1, 1995
Uninterrupted oral bisphosphonate (pamidronate) therapy of patients with osteoporosis is not associated with chronic stimulation of parathyroid hormone secretionJ O Landman, S E Papapoulos
Postgraduate Medical Journal|December 1, 1979
Control of hypercalcaemia in thyrotoxicosisM K Jones, S E Papapoulos
Bone and Mineral|January 1, 1993
Physicochemical considerations in the development and prevention of calcium oxalate urolithiasisD J Kok, S E Papapoulos
Annals of the Rheumatic Diseases|February 6, 2007
Changes in bone remodelling and antifracture efficacy of intermittent bisphosphonate therapy: implications from clinical studies with ibandronateS E Papapoulos, R C Schimmer
Postgraduate Medical Journal|July 23, 2008
Changes in bone remodelling and antifracture efficacy of intermittent bisphosphonate therapy: implications from clinical studies with ibandronateS E Papapoulos, R C Schimmer
Nederlands Tijdschrift Voor Geneeskunde|November 30, 1996
[Bisphosphonates in osteoporosis; a reevaluation]S E Papapoulos, J H Lockefeer
Cancer|August 1, 1991
The role of 1,25-dihydroxyvitamin D in the maintenance of hypercalcemia in a patient with an ovarian carcinoma producing parathyroid hormone-related proteinK Hoekman, Y I Tjandra, S E Papapoulos
Pageof 17

Showing results (11-20 of 162) with videos related to

Sort By:
Pageof 17
Nederlands Tijdschrift Voor Geneeskunde|March 30, 1991
[Diphosphonates in the treatment of osteoporosis]S E Papapoulos, J H Lockefeer
Seminars in Nuclear Medicine|February 24, 2001
The palliative management of skeletal metastases in prostate cancer: use of bone-seeking radionuclides and bisphosphonatesN A Hamdy, S E Papapoulos
Nederlands Tijdschrift Voor Geneeskunde|August 26, 1989
[Alkaline phosphatase level in bone diseases; frequently too high, sometimes too low]J D Macfarlane, S E Papapoulos
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 1, 1995
Uninterrupted oral bisphosphonate (pamidronate) therapy of patients with osteoporosis is not associated with chronic stimulation of parathyroid hormone secretionJ O Landman, S E Papapoulos
Postgraduate Medical Journal|December 1, 1979
Control of hypercalcaemia in thyrotoxicosisM K Jones, S E Papapoulos
Bone and Mineral|January 1, 1993
Physicochemical considerations in the development and prevention of calcium oxalate urolithiasisD J Kok, S E Papapoulos
Annals of the Rheumatic Diseases|February 6, 2007
Changes in bone remodelling and antifracture efficacy of intermittent bisphosphonate therapy: implications from clinical studies with ibandronateS E Papapoulos, R C Schimmer
Postgraduate Medical Journal|July 23, 2008
Changes in bone remodelling and antifracture efficacy of intermittent bisphosphonate therapy: implications from clinical studies with ibandronateS E Papapoulos, R C Schimmer
Nederlands Tijdschrift Voor Geneeskunde|November 30, 1996
[Bisphosphonates in osteoporosis; a reevaluation]S E Papapoulos, J H Lockefeer
Cancer|August 1, 1991
The role of 1,25-dihydroxyvitamin D in the maintenance of hypercalcemia in a patient with an ovarian carcinoma producing parathyroid hormone-related proteinK Hoekman, Y I Tjandra, S E Papapoulos
Pageof 17